New staph infection could be impossible to treat August 21, 1997 Web posted at: 11:06 p.m. EDT (0306 GMT) ATLANTA (CNN) -- A bacteria that can fend off one of the most powerful antibiotics -- the last pharmaceutical line of defense -- has appeared in the United States. The rare strain of staphylococcus aureus was first identified three months ago in Japan. The Centers for Disease Control and Prevention announced Thursday that a Michigan dialysis patient infected with staphylococcus aureus was not responding completely to the drug vancomycin. The germ showed an intermediate level of resistance to the drug, which is one step away from immunity, officials said. The patient now is being treated with a combination of drugs, including vancomycin. This tougher strain of staph was already difficult to treat. Doctors are now worried no treatment will be available for those infected with the deadly bacteria. Those most at risk are the elderly, those with weak immune systems, hospital patients, newborns and patients with chronic diseases. But Dr. William Jarvis, a medical epidemiologist with the CDC, said the new strain is rare. "The majority of people aren't going to be in danger of getting this." The evolution of resistance to antibiotics is inevitable, as bacteria grow and reproduce. "The cell wall has become much thicker," Jarvis said. "As a result, it is much more difficult for the antibiotic to go across that cell wall and get inside the cell" to kill the organism. Staph bacteria are the No. 1 cause of hospital infections. They are blamed for about 13 percent of the nation's 2 million hospital infections each year, according to the CDC. Overall, the 2 million infections kill 60,000 to 80,000 people. The Associated Press contributed to this report.